These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 17538930

  • 1. Tissue-type plasminogen activator deficiency exacerbates cholestatic liver injury in mice.
    Wang H, Zhang Y, Heuckeroth RO.
    Hepatology; 2007 Jun; 45(6):1527-37. PubMed ID: 17538930
    [Abstract] [Full Text] [Related]

  • 2. Transcriptional profiling after bile duct ligation identifies PAI-1 as a contributor to cholestatic injury in mice.
    Wang H, Vohra BP, Zhang Y, Heuckeroth RO.
    Hepatology; 2005 Nov; 42(5):1099-108. PubMed ID: 16250054
    [Abstract] [Full Text] [Related]

  • 3. PAI-1 deficiency reduces liver fibrosis after bile duct ligation in mice through activation of tPA.
    Wang H, Zhang Y, Heuckeroth RO.
    FEBS Lett; 2007 Jun 26; 581(16):3098-104. PubMed ID: 17561000
    [Abstract] [Full Text] [Related]

  • 4. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
    Giebeler A, Boekschoten MV, Klein C, Borowiak M, Birchmeier C, Gassler N, Wasmuth HE, Müller M, Trautwein C, Streetz KL.
    Gastroenterology; 2009 Jul 26; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
    [Abstract] [Full Text] [Related]

  • 5. Interleukin-6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a type I ductular reaction in mice: interactions between the periductal inflammatory and stromal cells and the biliary epithelium.
    Liu Z, Sakamoto T, Ezure T, Yokomuro S, Murase N, Michalopoulos G, Demetris AJ.
    Hepatology; 1998 Nov 26; 28(5):1260-8. PubMed ID: 9794910
    [Abstract] [Full Text] [Related]

  • 6. Antinecrotic and antiapoptotic effects of hepatocyte growth factor on cholestatic hepatitis in a mouse model of bile-obstructive diseases.
    Li Z, Mizuno S, Nakamura T.
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb 26; 292(2):G639-46. PubMed ID: 17068118
    [Abstract] [Full Text] [Related]

  • 7. Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: impaired activation of hepatocyte growth factor after Fas-mediated massive hepatic apoptosis.
    Shimizu M, Hara A, Okuno M, Matsuno H, Okada K, Ueshima S, Matsuo O, Niwa M, Akita K, Yamada Y, Yoshimi N, Uematsu T, Kojima S, Friedman SL, Moriwaki H, Mori H.
    Hepatology; 2001 Mar 26; 33(3):569-76. PubMed ID: 11230736
    [Abstract] [Full Text] [Related]

  • 8. Endogenous urokinase lacks antifibrotic activity during progressive renal injury.
    Yamaguchi I, Lopez-Guisa JM, Cai X, Collins SJ, Okamura DM, Eddy AA.
    Am J Physiol Renal Physiol; 2007 Jul 26; 293(1):F12-9. PubMed ID: 17356128
    [Abstract] [Full Text] [Related]

  • 9. Delayed treatment with plasminogen activator inhibitor-1 decoys reduces tubulointerstitial fibrosis.
    Gonzalez J, Klein J, Chauhan SD, Neau E, Calise D, Nevoit C, Chaaya R, Miravete M, Delage C, Bascands JL, Schanstra JP, Buffin-Meyer B.
    Exp Biol Med (Maywood); 2009 Dec 26; 234(12):1511-8. PubMed ID: 19934371
    [Abstract] [Full Text] [Related]

  • 10. Tissue-type plasminogen activator deficiency delays bone repair: roles of osteoblastic proliferation and vascular endothelial growth factor.
    Kawao N, Tamura Y, Okumoto K, Yano M, Okada K, Matsuo O, Kaji H.
    Am J Physiol Endocrinol Metab; 2014 Aug 01; 307(3):E278-88. PubMed ID: 24918201
    [Abstract] [Full Text] [Related]

  • 11. Acute obstructive cholangiopathy in interleukin-6 deficient mice: compensation by leukemia inhibitory factor (LIF) suggests importance of gp-130 signaling in the ductular reaction.
    Liu Z, Sakamoto T, Yokomuro S, Ezure T, Subbotin V, Murase N, Contrucci S, Demetris AJ.
    Liver; 2000 Apr 01; 20(2):114-24. PubMed ID: 10847479
    [Abstract] [Full Text] [Related]

  • 12. Reduced oncotic necrosis in Fas receptor-deficient C57BL/6J-lpr mice after bile duct ligation.
    Gujral JS, Liu J, Farhood A, Jaeschke H.
    Hepatology; 2004 Oct 01; 40(4):998-1007. PubMed ID: 15382126
    [Abstract] [Full Text] [Related]

  • 13. Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator.
    Bugge TH, Flick MJ, Danton MJ, Daugherty CC, Romer J, Dano K, Carmeliet P, Collen D, Degen JL.
    Proc Natl Acad Sci U S A; 1996 Jun 11; 93(12):5899-904. PubMed ID: 8650190
    [Abstract] [Full Text] [Related]

  • 14. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
    Allan EH, Martin TJ.
    J Cell Physiol; 1995 Dec 11; 165(3):521-9. PubMed ID: 7593231
    [Abstract] [Full Text] [Related]

  • 15. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network.
    Webb CP, Hose CD, Koochekpour S, Jeffers M, Oskarsson M, Sausville E, Monks A, Vande Woude GF.
    Cancer Res; 2000 Jan 15; 60(2):342-9. PubMed ID: 10667586
    [Abstract] [Full Text] [Related]

  • 16. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
    Leonardi A, Brun P, Sartori MT, Cortivo R, Dedominicis C, Saggiorato G, Abatangelo G, Secchi AG.
    Invest Ophthalmol Vis Sci; 2005 Apr 15; 46(4):1364-70. PubMed ID: 15790903
    [Abstract] [Full Text] [Related]

  • 17. Role of acid sphingomyelinase of Kupffer cells in cholestatic liver injury in mice.
    Osawa Y, Seki E, Adachi M, Suetsugu A, Ito H, Moriwaki H, Seishima M, Nagaki M.
    Hepatology; 2010 Jan 15; 51(1):237-45. PubMed ID: 19821528
    [Abstract] [Full Text] [Related]

  • 18. Effect of the plasminogen-plasmin system on hypertensive renal and cardiac damage.
    Knier B, Cordasic N, Klanke B, Heusinger-Ribeiro J, Daniel C, Veelken R, Hartner A, Hilgers KF.
    J Hypertens; 2011 Aug 15; 29(8):1602-12. PubMed ID: 21610512
    [Abstract] [Full Text] [Related]

  • 19. Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition.
    Pinsky DJ, Liao H, Lawson CA, Yan SF, Chen J, Carmeliet P, Loskutoff DJ, Stern DM.
    J Clin Invest; 1998 Sep 01; 102(5):919-28. PubMed ID: 9727060
    [Abstract] [Full Text] [Related]

  • 20. Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice.
    Lund LR, Green KA, Stoop AA, Ploug M, Almholt K, Lilla J, Nielsen BS, Christensen IJ, Craik CS, Werb Z, Danø K, Rømer J.
    EMBO J; 2006 Jun 21; 25(12):2686-97. PubMed ID: 16763560
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.